ArticleJournal of experimental & clinical cancer research : CR2026
RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemia.
Anudishi Tyagi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.